Chemotherapy-induced peripheral neuropathy Compression therapy with nitrile gloves Preventive effect-Study by randomized controlled trial-

Chemotherapy-induced peripheral neuropathy Compression therapy with nitrile gloves Preventive effect-Study by randomized controlled trial- - Chemotherapy-induced peripheral neuropathy Compression therapy with nitrile gloves Preventive effect-Study by randomized controlled trial-

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047423

Enrollment

100

Registered

2022-06-20

Start date

2022-06-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CANCER

Interventions

Start of chemotherapy - every day of chemotherapy Wear nitrile gloves for 30 minutes immediately before CIPN-prone drug administration, during administration, and 30 minutes after administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with cancer and receiving chemotherapy at Nagasaki University Hospital Patients undergoing preoperative or postoperative chemotherapy or chemotherapy for recurrence Patients receiving chemotherapy using taxane and platinum preparations Patients with consent to wear nitrile gloves

Exclusion criteria

Exclusion criteria: What researchers, etc. deem inappropriate as a researcher Requests not to participate in the research

Design outcomes

Primary

Measure	Time frame
CTCAE	—

Secondary

Measure	Time frame
FACT-GOG NTX Ver.4 NRS	—

Countries

Japan

Contacts

Public Contactmitsue kawata

Nagasaki University Hospital Chemotherapy room

hiranomitsue@nagasaki-u.ac.jp0958197787

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026